Halberd (Halberd) Additional Paid-In Capital : $5.92 Mil(As of Jul. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Halberd Additional Paid-In Capital?

Halberd's quarterly additional paid-in capital increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($5.67 Mil) and increased from Jul. 2022 ($5.67 Mil) to Jul. 2023 ($5.92 Mil).

Halberd's annual additional paid-in capital increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($5.67 Mil) and increased from Jul. 2022 ($5.67 Mil) to Jul. 2023 ($5.92 Mil).

Halberd Additional Paid-In Capital Historical Data

The historical data trend for Halberd's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Additional Paid-In Capital Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

Additional Paid-In Capital

5.67

5.92

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
Additional Paid-In Capital	-	5.67	5.92

Halberd Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Halberd Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Halberd's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236